COMPASS BIOTECHNOLOGIES INC.
CIK 0001327238
Revenue (TTM)
—
Q3 Oct 2011
Net Income (TTM)
−$1.19M
Q3 Oct 2011
EPS Diluted (TTM)
—
Q3 Oct 2011
Gross Margin
—
Q3 Oct 2011
Operating Margin
—
Q3 Oct 2011
Net Margin
—
Q3 Oct 2011
Free Cash Flow (TTM)
—
Q3 Oct 2011
Cash
$94
Q3 Oct 2011
Total Debt
—
Q3 Oct 2011
Shares Outstanding
23.92M sh
Q3 Oct 2011